Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 3/20 | 0.64 |
| ▸ | GGPS1 | O95749 | 8/20 | 0.58 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.58 |
| ▸ | MAPT | P10636 | 2/20 | 0.57 |
| ▸ | MEN1 | O00255 | 2/20 | 0.57 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.57 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.57 |
| ▸ | UGT1A1 | P22309 | 1/20 | 0.57 |
| ▸ | SQLE | Q14534 | 3/20 | 0.55 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28674475 | 1.00 | KMT2A (0.64) | KMT2AGGPS1ALOX15MAPTMEN1 | |
| SCHEMBL8623650 | 1.00 | KMT2A (0.64) | KMT2AGGPS1ALOX15MAPTMEN1 | |
| SCHEMBL4653602 | 1.00 | KMT2A (0.64) | KMT2AGGPS1ALOX15MAPTMEN1 | |
| SCHEMBL29616815 | 0.98 | KMT2A (0.60) | KMT2AGGPS1ALOX15MAPTMEN1 | |
| SCHEMBL27008003 | 0.98 | KMT2A (0.60) | KMT2AGGPS1ALOX15MAPTMEN1 | |
| SCHEMBL24728452 | 0.85 | KMT2A (0.67) | KMT2AGGPS1ALOX15MAPTMEN1 | |
| SCHEMBL16618412 | 0.84 | ALOX15 (0.64) | KMT2AGGPS1ALOX15MAPTMEN1 | |
| SCHEMBL16618409 | 0.84 | ALOX15 (0.64) | KMT2AGGPS1ALOX15MAPTMEN1 | |
| SCHEMBL5595879 | 0.83 | ALOX15 (0.68) | KMT2AGGPS1ALOX15MAPTMEN1 | |
| SCHEMBL5595884 | 0.83 | ALOX15 (0.68) | KMT2AGGPS1ALOX15MAPTMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 71 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3320907-A1 | TOPICAL FORMULATIONS FOR INCREASING THE DERMAL CONCENTRATION OF HYALURONIC ACID | Shamroc, Inc. (US) | 2018-05-16 | — | — | EP | claimed |
| US-9895393-B2 | Topical formulations for increasing the dermal concentration of hyaluronic acid | SHAMROC, INC. (US) | 2018-02-20 | — | — | US | claimed |
| US-9801807-B2 | Topical formulations for increasing the dermal concentration of hyaluronic acid | SHAMROC, INC. (US) | 2017-10-31 | — | — | US | claimed |
| US-9126060-B2 | Cosmetic use of geranylgeranyl-2-propanol | SEDERMA (FR) | 2015-09-08 | — | — | US | claimed |
| EP-2555743-B1 | COSMETIC USE OF GERANYLGERANYL-2-PROPANOL | SEDERMA SA (FR) | 2015-09-02 | — | — | EP | claimed |
| US-20130058878-A1 | Cosmetic Use Of Geranylgeranyl-2-Propanol | SEDERMA (FR) | 2013-03-07 | — | — | US | claimed |
| EP-2555743-A2 | COSMETIC USE OF GERANYLGERANYL-2-PROPANOL | Sederma (FR) | 2013-02-13 | — | — | EP | claimed |
| WO-2011125039-A2 | COSMETIC USE OF GERANYLGERANYL-2-PROPANOL | SEDERMA (FR) | 2011-10-13 | — | — | WO | claimed |
| JP-10167957-A | — | — | None | — | — | JP | disclosed |
| US-12440430-B2 | Use of tetrapeptides and functionalised microcapsules as skin penetration carriers | INFINITEC ACTIVOS S L (ES) | 2025-10-14 | — | — | US | disclosed |
| US-12419824-B2 | Compounds useful for the treatment and/or care of the skin, hair, nails and/or mucous membranes | LUBRIZOL ADVANCED MATERIALS, INC. (US) | 2025-09-23 | — | — | US | disclosed |
| EP-4573103-A1 | COMPOUNDS USEFUL FOR THE TREATMENT AND/OR CARE OF THE SKIN, HAIR, NAILS AND/OR MUCOUS MEMBRANES | Lubrizol Advanced Materials, Inc. (US) | 2025-06-25 | — | — | EP | disclosed |
| EP-4192419-B1 | EMULSIFIER COMPOSITION FOR PERSONAL CARE FORMULATION | LUBRIZOL ADVANCED MAT INC (US) | 2025-04-16 | — | — | EP | disclosed |
| EP-4493148-A1 | PROTEIN HYDROLYSATES OF AZUKI BEANS AND COSMETIC USES THEREOF | Lubrizol Advanced Materials, Inc. (US) | 2025-01-22 | — | — | EP | disclosed |
| EP-2555743-A2 | COSMETIC USE OF GERANYLGERANYL-2-PROPANOL | Sederma (FR) | 2013-02-13 | — | — | EP | disclosed |
| EP-2555743-A2 | COSMETIC USE OF GERANYLGERANYL-2-PROPANOL | Sederma (FR) | 2013-02-13 | — | — | EP | disclosed |
| WO-2011125039-A3 | COSMETIC USE OF GERANYLGERANYL-2-PROPANOL | SEDERMA (FR) | 2012-03-22 | — | — | WO | disclosed |
| WO-2011125039-A2 | COSMETIC USE OF GERANYLGERANYL-2-PROPANOL | SEDERMA (FR) | 2011-10-13 | — | — | WO | disclosed |
| WO-2011125039-A2 | COSMETIC USE OF GERANYLGERANYL-2-PROPANOL | SEDERMA (FR) | 2011-10-13 | — | — | WO | disclosed |
| JP-H10167957-A | INTERCELLULAR ADHESION SUPPRESSING AGENT | KAO CORP | 1998-06-23 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130058878-A1 | Cosmetic Use Of Geranylgeranyl-2-Propanol | TERT, GLA, TELO2 | KMT2A 3544/4885GGPS1 32/4885ALOX15 702/4885 |
| US-12419824-B2 | Compounds useful for the treatment and/or care of the skin, hair, nails and/or mucous membranes | TYR, TELO2, MTX2 | KMT2A 1405/4885GGPS1 4446/4885ALOX15 2713/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.